The Director of Health Economics and Outcomes Research is responsible for developing outcomes strategies and executing research projects which supports the value of our product portfolio throughout its lifecycle. The role will work with R&D to ensure products in development have the data required by payers and Medical Affairs and Commercial Franchise leaders to develop strategies for real-world evidence generation to support existing portfolio. This position requires strong technical skills to develop and execute evidence generation strategies and the ability to effectively interact with a variety of internal and external stakeholders to deliver priorities. The individual in this role should have a proven history of developing HEOR competencies within companies. The successful candidate will have a unique mix of skills including HEOR technical skill, ability to develop HEOR strategy aligned to product strategy, understanding how HEOR support both research and business objectives, educating non-experts on value of HEOR, and working with cross-functional teams.
• Establish and maintain cross-functional collaborative relationships with internal stakeholders, including R&D, Regulatory, Medical Affairs, Franchise leaders, Market Access at strategic and tactical levels to generate and disseminate robust HEOR findings in support of a broad set of stakeholders including payers
• Develop outcomes strategies for products in development to ensure evidence needed to support reimbursement are available at regulatory approval
• Work with Medical Affairs and brand teams to prioritize real-world evidence generation plans to support life cycle management for existing portfolio
• Work with the Market Access Operations to develop material for to support market access field team payer engagement
• Develop and communicate to key stakeholders across R&D and Commercial to ensure key initiatives are understood and appropriately funded
• Utilizes outcomes expertise to collaborate with key external thought-leaders [e.g. clinical, payer, patient advocacy etc] to develop research, execute protocols and/or publish finding
• Ensures timely execution of robust and innovative evidence aligned to strategy
• Responsible for functional and project budgets ensuring projects are delivered on time and within budget
• PharmD or PhD in Economics, Econometrics, or (pharmaco)epidemiology or any other related fields such as Health Services Research, Health Economics / Economics, Psychometrics, Epidemiology Health Policy, Outcomes Research, and Pharmacy Administration with at least 5 years of industry experience
• Expertise in real-world evidence generation and demonstrated success using real-world data, specifically claims, EMR/EHR, and registries, to support integrated evidence generation strategies and effectively design commercial research programs
• Experience in reimbursement and access, health economics and/or outcomes research as evidence by presentation and/or publication history
• Experience leading complex products and/or research in support of pipeline development and on-market product
• Knowledge of the global regulatory, health technology assessment and payer landscapes as well as understanding of other development-related functions as they relate to all phases of drug development
• Skills to perform the dual roles of leading a cross functional team and managing scientific personnel in clinical research
• Strong project management skills and ability to prioritize and manage multiple deliverables
• Strong analytic skills including data development and reporting capabilities are essential to build supporting material for presentation to leadership and other key stakeholders
• Strong presentation skills with clear and concise insights; must be able to interact successfully with senior management and act as the HEOR project/group champion and spokesperson
• Self-starter with ability to work independently and organize own work without continuous direct supervision
• Proven track record of strategic thinking, problem-solving, and decision-making capabilities
• 25-30% travel required
